Zydus Lifesciences has incorporated a wholly owned subsidiary company (WOS) namely Zydus Pharmaceuticals (Canada) Inc. The company has incorporated WOS on September 6, 2023 in Canada.
Earlier, the company had received final approval from the United States Food and Drug Administration (USFDA) for Erythromycin Tablets USP.
Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.